ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.749,54
-0,48%
S&P 500
5.460,18
-0,17%
US Dollar vs BRL
5,51613
1,17%
Bitcoin
61.771,81
-0,06%
Brent Oil
84,14
-0,05%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Kiora Pharmaceuticals Inc (KPRX)

  7. Kiora Pharmaceuticals Inc (KPRX) Notícias

KPRX

Kiora Pharmaceuticals (KPRX)

Kiora Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:KPRX
DataHoraFonteTítuloCódigoCompanhia
14/06/202417:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KPRXKiora Pharmaceuticals Inc
07/06/202408:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KPRXKiora Pharmaceuticals Inc
29/05/202416:47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KPRXKiora Pharmaceuticals Inc
28/02/202418:40Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:KPRXKiora Pharmaceuticals Inc
14/02/202418:55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KPRXKiora Pharmaceuticals Inc
14/02/202417:51Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:KPRXKiora Pharmaceuticals Inc
09/11/202309:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KPRXKiora Pharmaceuticals Inc
13/10/202318:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KPRXKiora Pharmaceuticals Inc
01/09/202308:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KPRXKiora Pharmaceuticals Inc
10/08/202318:23Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KPRXKiora Pharmaceuticals Inc
21/07/202317:49Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:KPRXKiora Pharmaceuticals Inc
11/07/202318:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:KPRXKiora Pharmaceuticals Inc
23/06/202309:35GlobeNewswire Inc.Life Science Investor Forum: Presentations Now Available for Online ViewingNASDAQ:KPRXKiora Pharmaceuticals Inc
21/06/202317:25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KPRXKiora Pharmaceuticals Inc
20/06/202311:58GlobeNewswire Inc.Life Science Investor Forum Agenda Announced for June 22ndNASDAQ:KPRXKiora Pharmaceuticals Inc
13/06/202317:03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KPRXKiora Pharmaceuticals Inc
02/06/202318:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(1) (424b1)NASDAQ:KPRXKiora Pharmaceuticals Inc
01/06/202307:01Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:KPRXKiora Pharmaceuticals Inc
15/05/202318:28Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:KPRXKiora Pharmaceuticals Inc
09/05/202308:00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KPRXKiora Pharmaceuticals Inc
05/05/202318:02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:KPRXKiora Pharmaceuticals Inc
28/04/202315:20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KPRXKiora Pharmaceuticals Inc
23/03/202308:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:KPRXKiora Pharmaceuticals Inc
13/02/202318:48Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:KPRXKiora Pharmaceuticals Inc
13/02/202318:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KPRXKiora Pharmaceuticals Inc
29/12/202208:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KPRXKiora Pharmaceuticals Inc
22/11/202215:55TipRanksKiora Pharmaceuticals (KPRX) Receives a Hold from Maxim GroupNASDAQ:KPRXKiora Pharmaceuticals Inc
14/11/202208:25TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Kiora Pharmaceuticals (KPRX)NASDAQ:KPRXKiora Pharmaceuticals Inc
10/11/202216:05TipRanksMaxim Group Reaffirms Their Hold Rating on Kiora Pharmaceuticals (KPRX)NASDAQ:KPRXKiora Pharmaceuticals Inc
25/10/202218:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KPRXKiora Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:KPRX

Seu Histórico Recente

TSXV
EGM.H
USOTC
HSCEF
HS (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados